| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13G | WOLVERINE ASSET MANAGEMENT LLC (Filed by) | ||
8-K | XFLH Capital Corporation Signs Letter of Intent for Business Combination with Renogen Biolab Inc. | ||
10-Q | Form 10-Q | ||
SCHEDULE 13G | Form SCHEDULE 13G | ||
SCHEDULE 13G | GOLDMAN SACHS GROUP INC (Filed by) | ||
10-Q | Form 10-Q | ||
SCHEDULE 13G | Shaolin Capital Management LLC (Filed by) | ||
4 | XFLH Holdings Ltd (Reporting) | ||
8-K | XFLH Capital Corporation Units to Separate into Ordinary Shares and Rights on March 9, 2026 | ||
8-K | XFLH Capital Corporation Financial Statements as of February 13, 2026, Detailing IPO Proceeds and Trust Account Setup | ||
SCHEDULE 13G | Form SCHEDULE 13G | ||
8-K | XFLH Capital Corporation Announces Pricing of $100 Million Initial Public Offering |
